Gilead Sciences (GILD) Cash & Equivalents (2009 - 2026)
Gilead Sciences posted quarterly Cash & Equivalents of $7.6 billion for Q1 2026, down 3.76% year-on-year from $7.9 billion in Q1 2025, and up 0.85% on a QoQ basis from $7.6 billion in Q4 2025.
Gilead Sciences (GILD) has 18 years of Cash & Equivalents data on file, last reported at $7.6 billion in Q1 2026.
- For the quarter ending Q1 2026, Cash & Equivalents fell 3.76% year-over-year to $7.6 billion; the trailing twelve-month figure through Mar 2026 stood at $7.6 billion (down 3.76% YoY), and the FY2025 full-year result was $7.6 billion, down 24.29% from the prior year.
- Cash & Equivalents for Q1 2026 stood at $7.6 billion, up from $7.6 billion in the prior quarter.
- Across five years, Cash & Equivalents topped out at $10.0 billion in Q4 2024 and bottomed at $2.8 billion in Q2 2024.
- The 5-year median for Cash & Equivalents is $5.4 billion (2022), against an average of $5.9 billion.
- The widest annual swing landed in 2024, when Cash & Equivalents sank 51.4%; it then surged 85.57% in 2025.
- A 5-year view of Cash & Equivalents shows it stood at $5.4 billion in 2022, then grew by 12.44% to $6.1 billion in 2023, then jumped by 64.19% to $10.0 billion in 2024, then decreased by 24.29% to $7.6 billion in 2025, then rose by 0.85% to $7.6 billion in 2026.
- The last three Cash & Equivalents figures came in at $7.6 billion (Q1 2026), $7.6 billion (Q4 2025), and $7.3 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 5.28 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 21.69 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 9.39 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 5.33 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 12.04 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 7.63 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 1.70 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 9.57 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 4.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.63 Bn |
| Dec 31, 2025 | 7.56 Bn |
| Sep 30, 2025 | 7.33 Bn |
| Jun 30, 2025 | 5.14 Bn |
| Mar 31, 2025 | 7.93 Bn |
| Dec 31, 2024 | 9.99 Bn |
| Sep 30, 2024 | 5.04 Bn |
| Jun 30, 2024 | 2.77 Bn |
| Mar 31, 2024 | 4.72 Bn |
| Dec 31, 2023 | 6.09 Bn |
| Sep 30, 2023 | 5.71 Bn |
| Jun 30, 2023 | 5.70 Bn |
| Mar 31, 2023 | 4.94 Bn |
| Dec 31, 2022 | 5.41 Bn |
| Sep 30, 2022 | 4.70 Bn |
| Jun 30, 2022 | 4.74 Bn |
| Mar 31, 2022 | 4.30 Bn |
| Dec 31, 2021 | 5.34 Bn |
| Sep 30, 2021 | 4.36 Bn |
| Jun 30, 2021 | 4.89 Bn |
| Mar 31, 2021 | 4.07 Bn |
| Dec 31, 2020 | 6.00 Bn |
| Sep 30, 2020 | 12.89 Bn |
| Jun 30, 2020 | 6.75 Bn |
| Mar 31, 2020 | 10.05 Bn |
| Dec 31, 2019 | 11.63 Bn |
| Sep 30, 2019 | 9.47 Bn |
| Jun 30, 2019 | 11.24 Bn |
| Mar 31, 2019 | 16.93 Bn |
| Dec 31, 2018 | 17.94 Bn |
| Sep 30, 2018 | 14.57 Bn |
| Jun 30, 2018 | 13.23 Bn |
| Mar 31, 2018 | 7.64 Bn |
| Dec 31, 2017 | 7.59 Bn |
| Sep 30, 2017 | 11.51 Bn |
| Jun 30, 2017 | 8.71 Bn |
| Mar 31, 2017 | 10.29 Bn |
| Dec 31, 2016 | 8.23 Bn |
| Sep 30, 2016 | 9.81 Bn |
| Jun 30, 2016 | 6.49 Bn |
| Mar 31, 2016 | 6.32 Bn |
| Dec 31, 2015 | 12.85 Bn |
| Sep 30, 2015 | 13.97 Bn |
| Jun 30, 2015 | 7.42 Bn |
| Mar 31, 2015 | 10.64 Bn |
| Dec 31, 2014 | 10.03 Bn |
| Sep 30, 2014 | 6.21 Bn |
| Jun 30, 2014 | 8.73 Bn |
| Mar 31, 2014 | 6.40 Bn |
| Dec 31, 2013 | 2.11 Bn |
| Sep 30, 2013 | 2.01 Bn |
| Jun 30, 2013 | 2.20 Bn |
| Mar 31, 2013 | 1.86 Bn |
| Dec 31, 2012 | 1.80 Bn |
| Sep 30, 2012 | 1.55 Bn |
| Jun 30, 2012 | 1.63 Bn |
| Mar 31, 2012 | 1.45 Bn |
| Dec 31, 2011 | 9.88 Bn |
| Sep 30, 2011 | 909.36 Mn |
| Jun 30, 2011 | 905.78 Mn |
| Mar 31, 2011 | 1.84 Bn |
| Dec 31, 2010 | 907.88 Mn |
| Sep 30, 2010 | 1.02 Bn |
| Jun 30, 2010 | 1.48 Bn |
| Mar 31, 2010 | 936.88 Mn |
| Dec 31, 2009 | 1.27 Bn |
| Sep 30, 2009 | 1.02 Bn |
| Jun 30, 2009 | 1.04 Bn |
| Mar 31, 2009 | 1.66 Bn |